Whether he will furnish Ms N N Chirwa with the full, relevant details on the final agreement stages with the pharmaceutical company, Johnson & Johnson, that he alluded to on Wednesday, 10 February 2021, in the Portfolio Committee on Health with regard to the (a) date on which the meetings between the specified company and the Government took place, (b) issues that were negotiated during all the proceedings with the company and (c) way forward in relation to procuring the specified vaccine; if not, why not; if so, what are the relevant details in each case?